top of page
ANTI-SCARRING GENE THERAPY
Cellastra is Pioneering Scar Prevention
Pulmonary Infections, Traumatic Brain Injury, Burn Injuries and Surgery
Cellastra is using proprietary AAV Technology to enable targeted production of antiscarring peptides
Now seeking qualified investors and development partners
Please see our Technology section for unique opportunities.
Cellastra News
CELLASTRA INC.
10/31/2025
Cellastra updated corporate presentation: 🔗
​​​
​
​​​
​​​​
​
bottom of page